Dose Escalation Study of Cu(II)ATSM in Parkinson's Disease
Clinical trial NCT03204929 · COMPLETED
Trial details
- NCT number
- NCT03204929
- Sponsor
- Collaborative Medicinal Development Pty Limited
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-14
- Primary completion
- 2019-11-30
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.